Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — FY2023 Earnings Presentation
56 slides from Aster Dm Healthcare's earnings presentation, May 25, 2023
Slide 1: Exchange filing cover letter
May 25, 2023 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 400051 Scr
Slide 2: Investor Presentation for the year ended 31st March 2023
Aster @) We'll Treat You Well INVESTOR PRESENTATION For the year ended 31st March 2023
Slide 3: Disclaimer
Disclaimer * This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other condit
Slide 4: Vision
VISION A Caring Mission with a Global Vision to Serve the World with Accessible and Affordable Quality Healthcare.
Slide 5: Aster DM Healthcare – Evolution
Aster DM Healthcare – Evolution New geographies, segments Brand “Aster” was formed, private Robust Growth across all Growth and Diversification into Building the foundations and service offerings equity investment, further expansion segments and geographies; Rapid aligned businesses across Expansion
Slide 6: Business Overview - FY23
Business Overview - FY23 32 (27) GCC : 15 (13) Largest Private Healthcare 5,756 GCC : 1,439 (1,160) Hospitals India : 171 (14) (5,065) India : 4,317 (3,905) Capacity Beds Presence in 7 Countries 19.9 Mn 127 (120) GCC : 115 (109) (18.6 Mn) GCC. : 16.9 Mn (16.3) India : 3.0 Mn5 (2.3) Clinics India : 1
Slide 7: Geographical Footprint
6 Geographical Footprint United Arab Emirates Kingdom of Saudi Arabia Kerala Andhra Pradesh Karnataka H(9) C(101) P(241) H(1) H(6) C(2) P(85) L(5) PEC(110) H(6) C(4) P(5) L(2) PEC(2) H(3) C(6) P(106) L(5) PEC(71) Oman Qatar Bahrain Jordan Maharashtra Telangana Tamil Nadu C(2) P(2) H(1) L(2) PEC(3) H
Slide 8: Aster DM Healthcare – Financial Overview
Aster DM Healthcare – Financial Overview
Slide 9: GCC Hospitals
GCC Hospitals 8 UAE Qatar Oman Saudi
Slide 10: India Hospitals
India Hospitals 9 Andhra & Telangana Cluster Kerala Cluster Karnataka & Maharashtra Cluster
Slide 11: Hospitals: Pipeline Projects
Hospitals: Pipeline Projects Owned / Hospitals - GCC Location Planned Beds Expected Completion Year Present Status Leased/O&M Owned / Hospitals - India Location Planned Beds Expected Completion Year Present Status Leased/O&M
Slide 12: The Aster DM Healthcare Edge
The Aster DM Healthcare Edge • • Sturdy • Performance Record • • Robust & Expansive • Healthcare Ecosystem • • Asset-Light Business • Proficient & Model • Experienced • Management Team • • De-Risked Business Model Touchstone of • Healthcare • Practices •
Slide 13: Historical Trends
Historical Trends Capacity Beds Outpatient Count (in mn) Inpatient Count (in ‘000) ..Coupled with capacity creation for further growth # of Units FY17 FY18 FY19 FY20 FY21 FY22 FY23 Hospitals 18 19 24 25 27 27 32 Clinics 96 101 114 117 115 120 127 Pharmacies - GCC 202 207 219 238 223 240 264 Pharmaci
Slide 14: An Integrated Healthcare Provider
AN INTEGRATED HEALTHCARE PROVIDER Aster – An Integrated Healthcare Provider
Slide 15: Aster - An Integrated Healthcare Provider
Aster - An Integrated Healthcare Provider FY23 Operational Information 1,800+ 326,300+ Cardiovascular IP Discharges Surgeries ~5.1 mn 22,800+ 1,300+ Clinic OPD Visits General Bariatric Surgeries Surgeries 4,000+ 1,500+ Joint ~ 9.8 mn Spine Replacements Pharmacy Surgeries Visits 17,700+ 400+ Urology
Slide 16: Aster – A Healthcare Ecosystem
Aster – A Healthcare Ecosystem Patient Life Cycle Management • Hospitals Clinics Pharmacies • • GCC INDIA • • Hospitals Clinics Resource Talent Management
Slide 17: Digital Health
Digital Health ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪
Slide 18: Origin, Legacy, Footprint, Profitability & Market Leader
PROFITABLITY & ORIGIN LEGACY FOOTPRINT PORTFOLIO MARKET LEADER
Slide 19: Footprint (India)
(INDIA) ❑ Vision ❑ ❑ ❑ Footprint Karnataka Kerala ❑ Telangana ❑ Andhra Pradesh *257 pharmacies in India operated by ARPPL under brand license from Aster
Slide 20: GCC Healthcare – Unique traits
GCC Healthcare – Unique traits Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) ➢ ➢ ➢ ➢ ➢ Seasonality of Patient Volumes ➢ ➢ ➢ ➢ ➢ Source : World Bank (2021 data) ➢ Source: 1. english.alarabiya.net ➢ 2. worldpopulationreview.com 3. omanobserver.com 4. edsfze.com
Slide 21: Aster - Awards & Service Excellence
Aster - Awards & Service Excellence 20 Dr. Azad Moopen • Alisha Moopen • • • • • • • • • • Accreditation from 6 JCI Accredited DNV Accreditation – European Society of Aster Hospital Mankhool, Orthopaedics Centre of Medical Oncology Qusais and Day Care “Saudi Central Board for Excellence Surgery Cent
Slide 22: Aster - Awards
Aster - Awards Times All India Multispecialty Outlook's Best Hospital Ranking UAE Innovation Award Hospitals Ranking Survey 2021 2022 Dubai Quality Award IHF LinkedIn Aster Top 5 DQA - DQAA Dubai Service Excellence ICC Healthcare Excellence Awards The Economics Times Healthcare Awards Aster No.155 F
Slide 23: Aster - Awards
Aster - Awards Asian Hospital Cyber Security Council Middle East Technology Management Awards Excellence Awards ARIS COE World AI Show & Awards – Arabia Corporate Social Best Project Implementation Responsibility Awards (AI Case Award) Excellence in therapeutic food International Patient Safety Awar
Slide 24: Operational and Financial Overview
OPERATIONAL AND FINANCIAL OVERVIEW Operational and Financial Overview
Slide 25: Clinical Highlights - FY23 Q4
Clinical Highlights - FY23 Q4 India ➢ ➢ ➢ ➢ ➢ ➢ GCC ➢ ➢ ➢ ➢ ➢
Slide 26: Revenue and Profitability Snapshot – FY23 Q4
Revenue and Profitability Snapshot – FY23 Q4 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ▪ Revenue excluding new hospitals4 is ▪ EBITDA excluding new hospitals4 is ▪ PAT (Post-NCI) excluding new Rs. 3,165 Crs. (Growth of 16%) Rs. 532 Crs. (Growth of 15%, EBITDA hospitals4 is R
Slide 27: Revenue and Profitability Snapshot – FY23
Revenue and Profitability Snapshot – FY23 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ▪ Revenue excluding new hospitals4 ▪ EBITDA excluding new hospitals4 ▪ PAT (Post-NCI) excluding new is Rs. 11,776 Crs. (Growth of 15%) is Rs. 1,655 Crs. (Growth of 11%, hospitals4 and one-tim
Slide 28: Geography – wise Financial Snapshot – Quarterly
Geography – wise Financial – Snapshot – Quarterly GCC INDIA CONSOLIDATED FY22 Q4 FY23 Q4 Gw (%) FY22 Q4 FY23 Q4 Gw (%) FY22 Q4 FY23 Q4 Gw (%) Revenue (₹) EBITDA (₹) PAT (Post-NCI) (₹) ➢ ➢ ➢ ➢
Slide 29: Geography – wise Financial Snapshot – FY23
Geography – wise Financial – Snapshot – FY23 GCC INDIA CONSOLIDATED FY22 FY23 Gw (%) FY22 FY23 Gw (%) FY22 FY23 Gw (%) Revenue (₹) EBITDA (₹) PAT (Post-NCI) (₹) ➢ ➢ ➢ ➢ 26%
Slide 30: Geography – wise Business Snapshot - Quarterly
Geography – wise Business – Snapshot - Quarterly GCC INDIA CONSOLIDATED FY22 Q4 FY23 Q4 FY22 Q4 FY23 Q4 FY22 Q4 FY23 Q4 Total Capacity Beds Operational Beds (Census) Operational Beds (Non-Census) Available Capacity Beds ALOS (Days) Occupancy Outpatient Visits In-patient visits ARPOBD (INR)
Slide 31: Geography – wise Business Snapshot – FY23
Geography – wise Business – Snapshot – FY23 GCC INDIA CONSOLIDATED FY22 FY23 FY22 FY23 FY22 FY23 Total Capacity Beds Operational Beds (Census) Operational Beds (Non-Census) Available Capacity Beds ALOS (Days) Occupancy Outpatient Visits In-patient visits ARPOBD (INR)
Slide 32: Geography – wise Business Snapshot – Quarterly (India clusters)
Geography – wise Business – Snapshot – Quarterly KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA FY22 Q4 FY23 Q4 FY22 Q4 FY23 Q4 FY22 Q4 FY23 Q4 FY22 Q4 FY23 Q4 Total Capacity Beds Operational Beds (Census) Operational Beds (Non-Census) Available Capacity Beds ALOS (Days) Occupancy Outpatien
Slide 33: Geography – wise Business Snapshot – FY23 (India clusters)
Geography – wise Business – Snapshot – FY23 KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA FY22 FY23 FY22 FY23 FY22 FY23 FY22 FY23 Total Capacity Beds Operational Beds (Census) Operational Beds (Non-Census) Available Capacity Beds ALOS (Days) Occupancy Outpatient Visits In-patient visits AR
Slide 34: Segmental Performance FY23 Q4 - India
Growth rates Hospitals & Hospitals & Clinics Hospitals - Labs & Unallocated Hospitals - Labs & Wholesale Unallocated & Clinics FY23 Q4 (Ex. O&M Asset Total O&M Asset Wholesale & Total O&M Asset Light Pharmacy Eliminations (Ex. O&M Light) Light Pharmacy Eliminations Asset Light) No. of Business Units
Slide 35: Segmental Performance FY23 - India
Segmental Performance FY23 - India Growth rates Hospitals & Hospitals & Clinics Hospitals - Labs & Unallocated Hospitals - Labs & Wholesale Unallocated & Clinics FY23 FY (Ex. O&M Asset Total O&M Asset Wholesale & Total O&M Asset Light Pharmacy Eliminations (Ex. O&M Light) Light Pharmacy Eliminations
Slide 36: Maturity Wise Hospital Performance – India FY23
Maturity Wise Hospital Performance – India FY23 ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹
Slide 37: Segmental Performance FY23 Q4 - GCC
Growth rates Unallocated & Unallocated & FY23 Q4 GCC Hospitals GCC Clinics GCC Pharmacies Total GCC Hospitals GCC Clinics GCC Pharmacies Total Eliminations Eliminations No. of Business Units (#) 15 115 264 NA 394 Operational Beds (#) 1,114 NA NA NA 1,114 Occupancy (%) 50% NA NA NA 50% In-patient Cou
Slide 38: Segmental Performance FY23 - GCC
Segmental Performance FY23 - GCC Growth rates Unallocated & Unallocated & FY23 FY GCC Hospitals GCC Clinics GCC Pharmacies Total GCC Hospitals GCC Clinics GCC Pharmacies Total Eliminations Eliminations No. of Business Units (#) 15 115 264 NA 394 Operational Beds (#) 1,114 NA NA NA 1,114 Occupancy (%
Slide 39: Maturity Wise Hospital Performance – GCC FY23
Maturity Wise Hospital Performance – GCC FY23 ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹
Slide 40: Financial Summary – Profitability Statement (1/2)
Financial Summary – Profitability Statement (1/2) Particulars (INR Cr) FY23 Q3 FY22 Q4 FY23 Q4 Y-o-Y Gw% Q-o-Q Gw% Revenue from operations 3,192 2,728 3,262 20% 2% Material consumption 954 703 927 Doctors cost 668 542 682 Employee cost (excl. doctors) 641 542 598 Laboratory outsourcing charges 20 55
Slide 41: Financial Summary – Profitability Statement (2/2)
Financial Summary – Profitability Statement (2/2) Particulars (INR Cr) FY22 FY23 Gw% Revenue from operations 10,253 11,933 16% Material consumption 2,892 3,532 Doctors cost 2,051 2,507 Employee cost (excl. doctors) 2,029 2,496 Laboratory outsourcing charges 255 71 Other expenses 1,544 1,762 EBITDA (
Slide 42: Financial Summary – Balance Sheet & Ratios
Financial Summary – Balance Sheet & Ratios As at Mar 31, As at Mar 31, As at Mar 31, As at Mar 31, Particulars (INR Cr) Consolidated (INR Cr) 2022 2023 2022 2023 LIABILITIES Gross Debt 2,192 2,287 Shareholders Equity 3,953 4,448 Less: Cash, Bank Balance and Current Investments 386 440 Minority Inter
Slide 43: Consol Trends - I
Consol Trends - | Revenue (INR Cr) 42 EBITDA 1,483 1,565 1,063 FY20 FY21 FY22 FY21. FY22 FY23 EBITDA Margin ROCE 9.7% 14.5% 14.5% 8.2% 12.3% 5.1% FY20 Fy21 FY22 FY21 FY22 FY23 EBITDA numbers are Post IndAS116 FY21 numbers have an impact of COVID
Slide 44: Consol Trends - II
Consol Trends - Il Net Debt (excl. Lease Liabilities) (INR Cr) mGCC mindia 2,784 FY20 FY21 FY22 FY23 43 Net Debt (incl. Lease Liabilities) (INR Cr) GCC mindia 5,416 5,260 FY20 FY21 FY22 FY23 Net Debt (excl. Lease Liabilities)/EBITDA 2.9 27 1.6 1.6 FY20 Fy21 Fy22 FY23 * Post IndAS 116 FY21 numbers ha
Slide 45: India: Financial Trends
India: Financial Trends Revenue EBITDA 2983 453 2384 353 1631 1654 183 144 FY20. FY21 FY22 FY23 FY20 FY21 FY22 FY23, EBITDA Margin PAT (post-NCl) 14.8% 15.2% 11.3% 8.7% 147 60 — -1.0% ~~ FY20 || FY22 FY23 FY20 FY21 FY22 FY23, Al
Slide 46: India Hospital & Clinics Cluster-Wise Trends
India Hospital & Clinics Cluster-Wise Trends
Slide 47: Strategy & Leadership
STRATEGY & LEADERSHIP Strategy & Leadership
Slide 48: GCC Strategy
GCC Strategy The pandemic allowed us to reflect and re- invent certain processes at all the locations. Enhanced use of digital means made us explore the power of digitization. We have launched Aster Digital Initiative with a strong focus on foundational and growth levers. Initiatives like Virtual Ca
Slide 49: India Strategy
India Strategy Aster DM Hospitals consistently amongst the top in google rankings and patient endorsements – Visibly growing appreciation in India for quality healthcare, clinical excellence and patient service
Slide 50: ESG: Committed to UN Sustainable Development Goals
ESG: Committed to UN Sustainable Development Goals
Slide 51: Story so far…
Story so far… External Assurance Materiality Assessment ESG Rating Partnered with Workshops KPMG for carrying out an independent Launched the assurance of our stakeholder Data Collation ESG report. To be engagement Partnered with completed by July process (both CRISIL rating agency 2023. internal an
Slide 52: ESG highlights for the year
ESG highlights for the year 93% energy consumption from renewable sources at Aster RV Bangalore 1,631 Employees been provided training on human rights issues 85% energy consumption from renewable 13,820 Kgs waste recycled at Medcare sources at Aster RV Bangalore Women and Children Hospital 95% mater
Slide 53: Aster – ESG Strategy
Aster – ESG Strategy Current ESG practices External engagement for ESG Policy and ESG Risk ESG Pillars identified in ESG assurance of Aster’s ESG framework approved by the Board level ESG commitment Report Aster Board report against global frameworks Next steps ▪ ▪
Slide 54: Aster Board of Directors
Aster Board of Directors Dr. Azad Moopen Alisha Moopen T. J. Wilson Anoop Moopen Shamsudheen Bin Daniel Robert Emmanuel David Mohideen Mammu Haji Mintz Gootam Purana Housdurgamvijaya Chenayappillil John James Mathew Wayne Earl Deepti George Keathley
Slide 55: Aster Leadership Team
Aster Leadership Team Dr. Azad Moopen T. J. Wilson Dr. Malathi Fara Siddiqi Alisha Moopen Veneeth Purushotaman Daniel Whitehead Rahul Kadavakolu Brandon Rowberry Dr. Sherbaz Bichu Dr. Shanila Laiju Bala NS Dr. Nitish Shetty Farhan Yasin Devanand K T Amitabh Johri Sunil Kumar M R Hitesh Dhaddha
Slide 56: Thank You
Aster We'll Treat You Well Thank You www.asterdmhealthcare.com Email: investors@asterdmhealthcare.com